Related Experiment Video

Updated: Dec 20, 2025

Intracellular Phosphoflow Cytometry of Acute Myeloid Leukemia Patient-Derived Xenotransplants
07:38

Intracellular Phosphoflow Cytometry of Acute Myeloid Leukemia Patient-Derived Xenotransplants

Published on: June 6, 2025

549

miR-486 is involved in the pathogenesis of acute myeloid leukemia by regulating JAK-STAT signaling

Cao Sha1, Gao Jia1, Zhao Jingjing1

  • 1Department of Oncology, The First People's Hospital of Lianyungang, No. 6 Zhenhua Earth Road, Lianyungang City, 222061, Jiangsu Province, People's Republic of China.

Naunyn-Schmiedeberg'S Archives of Pharmacology
|May 31, 2020
PubMed

Insights

MicroRNA-486 (miR-486) promotes acute myeloid leukemia (AML) cell growth by targeting suppressor of cytokine signaling 2 (SOCS2), enhancing the JAK-STAT3 pathway. This discovery offers new insights into AML pathogenesis and potential therapeutic strategies.

Area of Science:

  • Molecular Biology
  • Oncology
  • Genetics

Background:

  • Acute myeloid leukemia (AML) is a significant global health concern with complex subtypes.
  • Existing research highlights AML's association with cytogenetic heterogeneity and varied treatment responses.

Purpose of the Study:

  • To investigate the role of miR-486 in the pathogenesis of AML.
  • To identify molecular mechanisms underlying miR-486's function in AML.

Main Methods:

  • Analysis of The Cancer Genome Atlas (TCGA) database and patient tissues.
  • Short hairpin RNA (shRNA) mediated knockdown of miR-486.
  • miRNA profile analysis and dual-luciferase reporter assay.
  • Investigated the JAK-STAT3 signaling pathway.

Main Results:

  • miR-486 was found to be upregulated in AML.
  • Knockdown of miR-486 inhibited AML cell proliferation.
  • SOCS2 was identified as a direct target of miR-486.
  • miR-486 promotes cell proliferation by silencing SOCS2, thereby enhancing JAK-STAT3 activity.

Conclusions:

  • The miR-486-SOCS2-STAT3 axis plays a crucial role in AML pathogenesis.
  • This pathway represents a novel molecular mechanism in AML development.
  • Findings provide potential diagnostic and therapeutic targets for AML treatment.
Keywords:
Acute myeloid leukemiaJAK-STATProliferationSOCS2miR-486

More Related Videos

Myeloid Innate Signaling Pathway Regulation by MALT1 Paracaspase Activity07:09

Myeloid Innate Signaling Pathway Regulation by MALT1 Paracaspase Activity

Published on: January 7, 2019

7.8K
Proliferation and Differentiation of Murine Myeloid Precursor 32D/G-CSF-R Cells10:21

Proliferation and Differentiation of Murine Myeloid Precursor 32D/G-CSF-R Cells

Published on: February 21, 2018

10.3K

Related Concept Videos

The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
11.5K
MAPK Signaling Cascades01:07

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
7.7K
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a...
5.1K
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
5.0K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
4.5K
TGF - β Signaling Pathway01:16

TGF - β Signaling Pathway

The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors...
10.2K